Loading…
Based on limited metadata, CAO Group, Inc. received an FDA Warning Letter on October 15, 2018, regarding medical device manufacturing or distribution operations. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's medical device regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the particular compliance issues cited, the complete Warning Letter text would be required.